---
$id: https://graph.org.ai/products/commodity/51282128
$type: Product
source: UNSPSC
code: "51282128"
title: "Faropenem daloxate"
class: "51282100"
classTitle: "Beta-lactams"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Faropenem daloxate

**UNSPSC Code**: 51282128
**Class**: [Beta-lactams](Beta-lactams.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-lactam antibiotic with the molecular formula C17H19NO8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5OK523O4FU, chemically known as 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1r)-1-hydroxyethyl)-7-oxo-3-((2r)-tetrahydro-2-furanyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5r,6s), but more generally known as faropenem daloxate, which bears US NIH Compound Identifier 6918218. European Medicines Agency schedules faropenem daloxate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07512MIG. Most nations, for tariff purposes, schedule faropenem daloxate under HS 29419000. SMILES: CC1C(OC(=O)O1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4.

